Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ZB

WKN: A3EXDS | ISIN: KYG989MS1016 | Ticker:
NASDAQ
18.11.26 | 21:58
1,510 US-Dollar
+0,67 % +0,010
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED Chart 1 Jahr
5-Tage-Chart
ZHENGYE BIOTECHNOLOGY HOLDING LIMITED 5-Tage-Chart

Aktuelle News zur ZHENGYE BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrZhengye Biotechnology GAAP EPS of -$0.06, revenue of $7.51M1
12.11.Zhengye Biotechnology Holding Ltd - 6-K, Report of foreign issuer-
06.08.Zhengye Biotechnology regains Nasdaq bid price compliance; shares down2
22.07.Zhengye Biotechnology Stock Plunges Following 322% Rally In Volatile Reversal18
21.07.Zhengye Biotechnology Holding Ltd - 6-K, Report of foreign issuer1
21.07.Morning Market Movers: Zhengye Biotechnology, Lisata Therapeutics, Meiwu Technology, Danaher Corporation See Big Swings1.214WASHINGTON (dpa-AFX) - At 9:00 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen
21.07.Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity473Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development...
► Artikel lesen
ZHENGYE BIOTECHNOLOGY Aktie jetzt für 0€ handeln
04.06.Zhengye Biotechnology receives Nasdaq bid price deficiency notice2
04.06.Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency279Jilin, China, June 04, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development...
► Artikel lesen
04.06.Zhengye Biotechnology Holding Ltd - 6-K, Report of foreign issuer2
28.04.Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results355JILIN, China, April 28, 2026 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer...
► Artikel lesen
06.04.Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure371Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development...
► Artikel lesen
10.02.Zhengye Biotechnology Holding Limited Issues 2026 Chairman's Letter to Shareholders1.035Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1